pinktest_usa_0814|CSPHF|Short Name|pe_ratio|shareholder_yield_ttm|enterprise_value|cash_on_hand|average_volume_30|one_year_return|price|ps_ratio|market_beta_12_month|total_deposits|dividend_yield|average_shares_outs_diluted|price_next_month|price_second_month
pinktest_usa_0814|CSPHF|Long Name|CStone Pharmaceuticals PE Ratio|CStone Pharmaceuticals Shareholder Yield (TTM)|CStone Pharmaceuticals Enterprise Value (USD)|CStone Pharmaceuticals Cash and Short Term Investments (Quarterly) (USD)|CStone Pharmaceuticals 30-Day Average Daily Volume|CStone Pharmaceuticals 1 Year Price Returns (Daily)|CStone Pharmaceuticals Price (USD)|CStone Pharmaceuticals PS Ratio|CStone Pharmaceuticals Beta (1Y)|CStone Pharmaceuticals Total Deposits (Quarterly) (USD)|CStone Pharmaceuticals Dividend Yield|CStone Pharmaceuticals Average Diluted Shares Outstanding (Quarterly)||
pinktest_usa_0814|CSPHF|Unit|figure_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_money_USD_price|figure_USD_metric|figure_USD_beta|mil_figure_money_USD_metric|percent_USD_metric|mil_figure_USD_metric||
pinktest_usa_0814|CSPHF|201712||||82.3584||||||||984.0515||
pinktest_usa_0814|CSPHF|201809||||249.2527||||||||984.0515||
pinktest_usa_0814|CSPHF|201812||||226.4812||||||||984.0515||
pinktest_usa_0814|CSPHF|201906||||485.8373||||||||||
pinktest_usa_0814|CSPHF|201912||||391.9813||||||||||
pinktest_usa_0814|CSPHF|202006||||301.2096||||||||||
pinktest_usa_0814|CSPHF|202009|||1135.7513||||1.36||||0||1.44|1.44